NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...

Expert behavioral medicine specialists and neurologists at the WVU Rockefeller Neuroscience Institute (RNI) offer an alternative and complementary treatment option for adult patients who have major ...

Moment of Clarity has published a new educational resource on insurance coverage considerations for transcranial magnetic ...

Repetitive transcranial magnetic stimulation (rTMS) is associated with reduced symptom severity in patients with comorbid major depressive disorder (MDD) and substance use disorders (SUDs), new ...

Repetitive transcranial magnetic stimulation was effective in routine treatment of medication-resistant major depression, according to findings published in the Journal of Affective Disorders.

The landscape of mental health treatment is undergoing a significant transformation, driven by groundbreaking research and novel therapeutic interventions. From the revolutionary potential of ...

BrainsWay Ltd. BWAY recently announced an expansion of insurance coverage for its Deep TMS therapy in adolescent depression. The update signals growing payer confidence in non-drug neurostimulation ...

LOS ANGELES, Nov. 28, 2017 (GLOBE NEWSWIRE) -- TMS Neuro Institute, led under the direction of Dr. Gennady Musher, MD, Phd, and Faculty Member at UCLA, has officially opened its doors in Los Angeles.

Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that delivers magnetic pulses to the brain to change neural activity. It is used to treat mental health disorders, particularly ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers analyzed 110 studies with 4,820 participants ...